Akcea Therapeutics Inc. (AKCA) announced Thursday morning that it has entered into an exclusive, worldwide license agreement with Ionis Pharmaceuticals (IONS) for inotersen and AKCEA-TTR-LRx.
from RTT - Before the Bell http://ift.tt/2DxqFfs
via IFTTT
No comments:
Post a Comment